
Regulatory, compliance issues continue to weigh down Invacare
Regulatory and compliance issues have diverted resources at home health products supplier Invacare (NYSE:IVC) away from “critical priorities” in the company’s business and have resulted in delays of new product introductions and slowed progress on a key globalization initiative. Those issues stem from negotiations with the U.S. Food and Drug Administration over a possible shutdown […]